Virax Biolabs Group Limited (VRAX) has a market capitalization of $650.43K and trades at $0.15. The 52-week range is 0.152-1.34.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-1.96, annual revenue of $6.33K.
The stock has a beta of 1.60, operates in the Healthcare sector.
